Brief: Mereo Biopharma Reports Full Year 2022 Financial Results And Recent Highlights
28/03/2023 23:32
March 28 (Reuters) - Mereo Biopharma Group PLC
MAH0y.F :
* MEREO BIOPHARMA REPORTS FULL YEAR 2022 FINANCIAL RESULTS
AND
RECENT HIGHLIGHTS
* MEREO BIOPHARMA - SEES EXISTING CASH AND SHORT-TERM
DEPOSITS TO
ENABLE IT TO FUND CLINICAL TRIALS, OPERATING EXPENSES, CAPEX
REQUIREMENTS INTO 2026
Source text for Eikon: ID:nGNX8znJrr
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand